UNSPSC 51283914: Sulfaguanidine

This classification denotes a sulfonamide anti-infective agent with the molecular formula C7H10N4O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 15XQ8043FN, chemically known as sulfanilamide, n(sup1)-amidino- but generally known as sulfaguanidine, which bears US NIH Compound Identifier 5324. European Medicines Agency schedules Sulfaguanidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10703MIG.

UNSPSC 51283914 Sulfaguanidine is a Commodity code for a specific pharmaceutical active ingredient; however, the recent state and local contract opportunities tagged under this code show minimal relevant activity. The Illinois Department of Public Health's completed award through the MMCAP Infuse consortium supplied Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets—antibiotics unrelated to sulfaguanidine—totaling $2,999,999.11 over a three-year contract with Chartwell Rx LLC. Seminole County, Florida's competitive bidding for Naloxone and Safe Drug Deactivation Systems similarly does not align with the sulfaguanidine commodity classification. State and local procurement offices appear to use this code inconsistently or tag pharmaceutical warehouse and emergency-response contracts without strict adherence to active-ingredient specificity.

The geographic spread reflected in recent opportunities includes Illinois and Florida, though the Seminole County solicitation carried a due date of July 26, 2023—substantially predating the current window. The Illinois award, issued August 28, 2026, represents the most recent activity. No standout repeat buyers or emerging procurement patterns under this specific code are evident from the available records. Business development professionals should verify whether sulfaguanidine procurement actually occurs in target markets and whether state and local buyers are tagging opportunities under this code accurately, as the mismatch between the code's nominal scope and the antibiotics and emergency-response products actually being procured suggests inconsistent taxonomy application rather than active market demand for this specific ingredient.